Cooley Advises Jazz Pharmaceuticals in $314.4 Million Offering

Palo Alto, Calif. – March 8, 2013 – Cooley LLP announced today that it advised Jazz Pharmaceuticals plc (NASDAQ: JAZZ) in a recent $314.4 million public offering of its ordinary shares by certain of Jazz Pharmaceutical's existing shareholders, including entities affiliated with Kohlberg Kravis Roberts, Longitude Capital Partners and Beecken Petty O'Keefe & Company.  Jazz Pharmaceuticals, a long-time Cooley client, is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company, which is headquartered in Dublin, Ireland with multiple offices in the United States, the United Kingdom and other countries in Europe, has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. 

The Cooley securities team that advised Jazz Pharmaceuticals was led by partners Chad Mills and Charlie Kim and included associates Matthew Dubofsky, Christine Liu and Michael Wu. Tax advice was provided by partners Mark Windfeld-Hansen and Mark Hrenya; regulatory advice was provided by partners Natasha Leskovsek and Drew Gantt; and intellectual property advice was provided by partners Bill Christiansen and Erich Veitenheimer.

About Cooley LLP

Cooley's 700 attorneys have an entrepreneurial spirit and deep, substantive experience, and are committed to solving clients' most challenging legal matters. From small companies with big ideas to international enterprises with diverse legal needs, Cooley has the breadth of legal resources to enable companies of all sizes to seize opportunities in today's global marketplace. The firm represents clients across a broad array of dynamic industry sectors, including technology, life sciences, venture capital, clean energy, real estate and retail.

The firm has full-service offices in eleven major business and technology centers: Boston, MA; Broomfield, CO; Los Angeles, CA; New York, NY; Palo Alto, CA; Reston, VA; San Diego, CA; San Francisco, CA; Seattle, WA; Washington, DC; and Shanghai, China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.